Di Martino V
-
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
-
Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?
-
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.